Collagen Booster Microneedle Device Market Report 2025

The collagen booster microneedle device market size has grown rapidly in recent years. It will grow from $0.47 billion in 2024 to $0.52 billion in 2025 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period is attributed to increasing demand for non-invasive aesthetic treatments, rising awareness of skin rejuvenation benefits, higher disposable income supporting cosmetic procedures, growing preference for at-home skincare solutions, and the expanding influence of social media and beauty influencers.

The collagen booster microneedle device market size is expected to see rapid growth in the next few years. It will grow to $0.77 billion in 2029 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period is driven by increasing aesthetic consciousness, an aging population, availability of at-home devices, rising geriatric population, and heightened concerns about skin aging. Key trends in the forecast period include the integration of radiofrequency technology, growth of homecare microneedling devices, focus on skin rejuvenation, preference for automated microneedling pens, and expansion in hair restoration applications.

The increasing popularity of minimally invasive cosmetic procedures is anticipated to drive the growth of the collagen booster microneedle device market. These procedures are non-surgical treatments that enhance physical appearance while offering reduced recovery time and fewer risks compared to traditional surgical options. The rising demand is largely attributed to consumer preference for safer alternatives that require minimal downtime, as modern lifestyles increasingly favor quick recovery and natural-looking results without the complications linked to invasive surgery. Collagen booster microneedle devices support these procedures by creating controlled micro-injuries in the skin, which activate the body's natural healing response, leading to increased collagen production and skin rejuvenation without surgical methods. For example, in June 2024, the American Society of Plastic Surgeons reported that there were 347,782 liposuction procedures in 2023, reflecting a seven percent rise from 2022. Additionally, plastic surgeries grew by five percent year-over-year, while minimally invasive procedures saw a seven percent increase. As a result, the growing demand for minimally invasive cosmetic procedures is contributing to the expansion of the collagen booster microneedle device market.

Leading companies in the collagen booster microneedle device market are adopting innovative technologies such as advanced retraction systems to improve treatment accuracy, enhance patient safety, and achieve more consistent aesthetic results. Advanced retraction systems represent a breakthrough in microneedling by automatically retracting the needles after each insertion, which helps to minimize tissue damage, improve patient comfort, and ensure safer and more accurate treatments. For instance, in September 2024, Crown Aesthetics Inc., a medical aesthetics company based in the United States, received approval from the United States Food and Drug Administration for its new SkinPen Precision Elite. This device features ActiSine technology with active retraction, a cartridge system with radio-frequency identification, and improved safety features. It functions by creating controlled micro-injuries in the skin, stimulating the natural wound-healing process, and promoting the production of collagen and elastin to enhance the appearance of acne scars, wrinkles, and skin texture. This development aims to optimize both provider efficiency and patient outcomes by offering enhanced precision, reliability, and comfort during procedures, setting a new standard in the collagen booster microneedle device market with its combination of safety, ease of use, and clinically validated rejuvenation benefits.

In June 2025, Richards Packaging Income Fund, a company based in Canada, completed the acquisition of DermapenWorld Pty Ltd. for forty million United States dollars. Through this acquisition, Richards Packaging Income Fund intends to broaden its healthcare portfolio by incorporating DermapenWorld, a prominent manufacturer of microneedling devices and dermatological skincare products. The acquisition allows the company to strengthen its healthcare offerings by integrating DermapenWorld's established brand and products with its current range. DermapenWorld Pty Ltd. is a manufacturing firm based in Australia, specializing in collagen booster microneedle devices.

Major players in the collagen booster microneedle device market are Shiseido Company Limited, Cynosure Inc., Cutera Inc., Sincoheren Co. Ltd., Crown Aesthetics Inc., Amiea Med GmbH, Beijing Sanhe Beauty Science & Technology Co. Ltd., EndyMed Medical Ltd., Eclipse MedCorp LLC, Bomtech Electronics Co. Ltd., DermaQuip Inc., Aesthetics Biomedical Inc., RegenOMedix Inc., Emage Medical Inc., Medicube Co. Ltd., FotroMed Co. Ltd., Korabeauticals Inc., Accio Biotech Inc., Astiland Co. Ltd., Shenzhen GSD Technology Co. Ltd.

North America was the largest region in the collagen booster microneedle device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in collagen booster microneedle device report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the collagen booster microneedle device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

A collagen booster microneedle device is a skincare tool intended to stimulate collagen production in the skin through controlled micro-injuries. It employs fine needles to trigger natural healing processes, enhancing skin firmness, elasticity, and texture. The device supports better absorption of active ingredients, aiding overall skin rejuvenation and promoting a youthful appearance.

The primary types of collagen booster microneedle devices are manual microneedle devices and automated microneedle devices. A manual microneedle device is a hand-operated tool that delivers tiny needles into the skin for cosmetic or therapeutic purposes without electronic assistance. They are distributed through online retail, pharmacies, specialty stores, and other channels. Applications include anti-aging, scar treatment, skin rejuvenation, hyperpigmentation, and other indications. End-users include dermatology clinics, hospitals, homecare settings, and other healthcare providers.

The collagen booster microneedle device market research report is one of a series of new reports that provides collagen booster microneedle device market statistics, including collagen booster microneedle device industry global market size, regional shares, competitors with the collagen booster microneedle device market share, collagen booster microneedle device market segments, market trends, and opportunities, and any further data you may need to thrive in the collagen booster microneedle device industry. This collagen booster microneedle device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The collagen booster microneedle device market consists of sales of microneedling patches, collagen-boosting serums and ampoules, at-home microneedling devices, and rf microneedling devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.